Onderneming Nunzia Pharmaceutical Corporation Other OTC
Aandelen
NUNZ
US67097W1027
Farmaceutische producten
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Sara Gonzales
CEO | Chief Executive Officer | 51 | - |
President | 68 | 01-01-09 | |
Shujie Cui
CTO | Chief Tech/Sci/R&D Officer | 62 | 05-12-19 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
President | 68 | 01-01-09 | |
Shujie Cui
CTO | Chief Tech/Sci/R&D Officer | 62 | 05-12-19 |
Sara Gonzales
CEO | Chief Executive Officer | 51 | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 51 000 | 0 | 0 | 18,04 % |
Aandeel B | 1 | 434 514 578 | 78 406 578 ( 18,04 %) | 0 |
Bedrijfsgegevens
Nunzia Pharmaceutical Corp.
1627 West 14th Street
90813, Long Beach
+714 609 9117
![Adres Nunzia Pharmaceutical Corporation(NUNZ)](https://cdn.zonebourse.com/static/address/5838936.png)
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+50,70% | 791 mld. | |
+41,46% | 630 mld. | |
+18,77% | 328 mld. | |
+8,79% | 298 mld. | |
+17,66% | 246 mld. | |
+0,20% | 225 mld. | |
+10,20% | 218 mld. | |
+3,68% | 160 mld. | |
-4,38% | 156 mld. |